Golimumab for the treatment of rheumatoid arthritis
13 May 2011
The British Society for Rheumatology (BSR) welcomes the guidance from National Institute of Health and Clinical Excellence (NICE) on the use of Golimumab for patients with rheumatoid arthritis.
Dr Ian Rowe, Chair of BSR Clinical Affairs Committee said; “We are very pleased that NICE has given positive guidance on the use of Golimumab for patients with rheumatoid arthritis . This offers patients with rheumatoid arthritis the opportunity to get this new treatment and benefit from the advantages the treatment may have. It also allows clinicians more options to treat patients, enabling the treatment of this disease to be more effective.”
For further details contact: Debbie Smith